Sialic acid content of erythrocytes in normal individuals and patients with certain hematologic disorders.
The sialic acid content of erythrocytes from healthy individuals of different blood types and of patients with known hematological disorders has been determined. The sialic acid was completely released enzymatically with sialidase and quantitated by the thiobarbituric acid method. The sialic acid content of erythrocytes was constant irrespective of ABO blood type, or anticoagulant used; viz, 0.85-0.92 mumoles/ml of packed erythrocytes or 46-53 X 10(6) sialyl residues per cell. Deviations from these normal values were obtained with erythrocytes from patients with a variety of hematological disorders. Patients with the following disorders have significantly (P less than 0.01) lower sialic acid values compared to erythrocytes from healthy individuals (given in the order of decreasing sialic acid content): sickle cell anemia, acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myelomonocytic leukemia, non-Hodgkin lymphocytic lymphoma, chronic granulocytic leukemia, acute myelocytic leukemia, leukemia, and Hodgkin disease.
D000017:ABO Blood-Group System; D000755:Anemia, Sickle Cell / Q000097:blood; D000925:Anticoagulants / Q000494:pharmacology; D004912:Erythrocytes / Q000032:analysis* / Q000187:drug effects; D006402:Hematologic Diseases / Q000097:blood*; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D007938:Leukemia / Q000097:blood; D012794:Sialic Acids / Q000097:blood*
D000017:ABO Blood-Group System; D000925:Anticoagulants; D012794:Sialic Acids